"When I was at Amgen, Inc., Roger Perlmutter [executive VP and head of R&D] used to say: 'We need to move things forward quickly, because the real experiments are in humans.' "
Podcast: Bioprinting – An Innovative Tool That Is Revolutionizing Drug Discovery
Keith Murphy, co-founder of Organovo, discusses the growing potential of bioprinting and how the company is using its technologies to study and develop treatments for inflammatory bowel disease (IBD).
